C Simard

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• Inserm10.6%
• Vertex Pharmaceuticals (United States)9.4%
• German Center for Lung Research8.8%
• University of North Carolina at Chapel Hill7.8%
• Cystic Fibrosis Foundation7.6%
• University of Alabama at Birmingham7.5%
• Other48.3%

Fields

• Medicine78%
• Biochemistry, Genetics and Molecular Biology12.8%
• Psychology4.8%
• Neuroscience1.5%
• Pharmacology, Toxicology and Pharmaceutics0.6%
• Chemistry0.5%
• Other1.8%

Topics

• Cystic Fibrosis Research Advances34.8%
• Neonatal Respiratory Health Research14.2%
• Chronic Obstructive Pulmonary Disease (COPD) Research8.4%
• Tracheal and airway disorders6.6%
• Asthma and respiratory diseases5.4%
• Cardiovascular and exercise physiology5.1%
• Other25.5%